IP Verse

Molnia patent opposition analysis

The comprehensive analysis of Molnia opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Molnia

Stay updated with the latest patent oppositions filed by Molnia

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4162934
Nutritional ProductUCL BUSINESSJul 29, 2025MOLNIA
EP2818163
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025RATIOPHARM
EP4069368
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DORRIES
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024DORRIES
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DORRIES
EP3167888
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024AMGEN TECHNOLOGY IRELAND UNLIMITED
EP3791896
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGEOct 10, 2024DR H ULRICH DORRIES
EP3973987
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 1, 2024DR H ULRICH DORRIES
EP3703818
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYAug 1, 2024DR H ULRICH DORRIES
EP4011915
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 3, 2024DR H ULRICH DORRIES

Top clients of Molnia

Top companies who are the clients of Molnia

CompanyTotal
MOLNIA152
DR H ULRICH DORRIES22
DORRIES5
PFIZER5
ZOETIS SERVICES3
AMGEN3
AMGEN TECHNOLOGY IRELAND UNLIMITED2
BOLTON MEDICAL1
FRIEDRICH1
LOHMANN1